1992
DOI: 10.1016/0002-8703(92)90665-i
|View full text |Cite
|
Sign up to set email alerts
|

Stimulation of coronary collateral growth: Current developments in angiogenesis and future clinical applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
12
0
1

Year Published

1992
1992
2011
2011

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(14 citation statements)
references
References 75 publications
1
12
0
1
Order By: Relevance
“…This research highlights the therapeutic possibilities for controlled vascular development and angiogenesis (Unger et al, 1990). Such treatment, potentially, could both inhibit pathological vascular growth, and enhance the development of collateral arteries subsequent to myocardial ischemia (Kass et al, 1992).…”
Section: Clinical Applicationsmentioning
confidence: 92%
“…This research highlights the therapeutic possibilities for controlled vascular development and angiogenesis (Unger et al, 1990). Such treatment, potentially, could both inhibit pathological vascular growth, and enhance the development of collateral arteries subsequent to myocardial ischemia (Kass et al, 1992).…”
Section: Clinical Applicationsmentioning
confidence: 92%
“…Its expression -at least in tissue cultures -increases very rapidly during exposure to hypoxia [247] and its half-life is then pro longed from 30 min to 8 h [248], It selectively upregulates expression of proteases involved in the disruption of the basement membrane [249], releasing stored bFGF. which could explain its potentiating effect on bFGF [250], Isch aemia is considered a very potent stimulus for the devel opment of collateral circulation in the heart [251] and VEGF may play a crucial role in this. Relative ischaemia also leads to accumulation of adenosine which has a direct angiogenic effect on endothelial cells derived from coro nary microvasculature [252], Another mediator in the development of collateral cir culation may be heparin which, given by infusion, pro moted ingrowth of vessels into the heart from the internal mammary artery [253].…”
Section: Vesselsmentioning
confidence: 99%
“…However, as a confounding problem, even when the culprit vessel is occluded, flow may still reach the ischemic territories using a pathway of collateral circulation: pre-existing or newly formed vessels from one coronary vascular bed that connect with an adjacent bed (15)(16)(17). The degree of collateralization varies between species; in the absence of coronary artery disease, it is more extensive in normal dogs than in normal humans (18).…”
mentioning
confidence: 99%
“…The degree of collateralization varies between species; in the absence of coronary artery disease, it is more extensive in normal dogs than in normal humans (18). However, collateral growth and recruitment can be stimulated by gradual narrowing of the coronary arteries, intermittent periods of ischemia or by total occlusion although the former two are more effective (16,19). Because AMI generally occurs in the setting of atherosclerotic narrowed coronary arteries (20), intermittent episodes of ischemia, although often asymptomatic (silent ischemia (5)), may stimulate the growth and proliferation of collateral circulation.…”
mentioning
confidence: 99%